HEPARFLOW - Intraoperative Evaluation of the Hepatic Artery Flow during Pancreatoduodenectomy - An Explorative Study

• Conditions: C25; D37.70; K86; Malignant neoplasm of pancreas; Other diseases of pancreas

• Registration Number: DRKS00014620
• Lead Sponsor: niversitätsklinikum Heidelberg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-07-10
• Study Completion: 2019-03-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients scheduled for partial or total pancreatoduodenectomy (open); Patients over 18 years; Written informed consent; Ability of subject to understand character and individual consequences of the clinical trial

Exclusion Criteria

Patients having previously received operations on upper gastrointestinal organs (esophageal resection, gastric surgery, splenectomy, liver resection of one or more segments, liver transplantation, pancreas left resection, vascular surgery of the visceral vessels); Liver cirrhosis and other severe liver disease; Bilirubin over 15 mg/dl

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Flow rates in the proper hepatic artery, gastroduodenal artery and other relevant vessels for the liver blood supply and their variations during pancreatoduodenectomy.

Secondary Outcome Measures

Name	Time	Method
Postoperative complication rate based on variations of hepatic blood flow during pancreatic surgery.